(αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol

• CAT Number: R063332
• CAS Number: 205393-21-1
• Molecular Formula: C24H38BClN2O3
• Molecular Weight: 448.839
• Purity: ≥95%
• Synonyms: [3aS-[2[S*(R*)],3aα,4β,6β,7aα]]-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride; Bortezomib Intermediates II
• Storage: -20 ℃
• InChI: InChI=1S/C24H37BN2O3.ClH/c1-15(2)11-21(27-22(28)18(26)12-16-9-7-6-8-10-16)25-29-20-14-17-13-19(23(17,3)4)24(20,5)30-25;/h6-10,15,17-21H,11-14,26H2,1-5H3,(H,27,28);1H/t17-,18-,19-,20+,21-,24-;/m0./s1
• InChIKey: BYRWVECJDRGBAH-UMPWXGAWSA-N
• SMILES: B1(OC2CC3CC(C3(C)C)C2(O1)C)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)N.Cl

(αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol is a complex compound of interest in medicinal chemistry and drug design. This structure features a unique combination of an amino group and a bicyclic boron-containing framework, which may enhance its biological activity. The stereochemical configuration suggests potential specificity in interacting with biological targets. Ongoing research focuses on its pharmacological properties, exploring its applications in therapeutic contexts such as enzyme inhibition or modulation of biological pathways.